SCHEDULE 13D

Company

TRINITY BIOTECH PLC

Filed

December 8, 2022

Accession Number

0001341004-22-000364

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →